Industry: Medical Devices & Consumables
Published Date: 2026-04-17
Pages: 120 Pages
Report ld: 6468979
Request Sample
Customized Report
Human iPS Cell Characterization Kit Market Size(US$)

CAGR 2026-2032
7.8%
Market Size,2032
USD 1,927
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Human iPS Cell Characterization Kit market was valued at US$ 1148 million in 2025 and is anticipated to reach US$ 1927 million by 2032, at a CAGR of 7.8% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Human iPS Cell Characterization Kit competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The Human iPS Cell Characterization Kit (Induced pluripotent stem cell) contains a range of sensitive tools for the phenotypic assessment of the pluripotent status of human Embryonic stem & induced pluripotent Stem cells.
Life science reagents are the fundamental materials for life science research and development, and are widely used as consumable tools in life science research activities. According to Frost&Sullivan"s data, the global market size of biological reagents has reached US $12.8 billion in 2015 and US $17.5 billion in 2019, with a Compound annual growth rate of 8.1%.
This report delivers a comprehensive overview of the global Human iPS Cell Characterization Kit market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Human iPS Cell Characterization Kit. The Human iPS Cell Characterization Kit market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Human iPS Cell Characterization Kit market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Human iPS Cell Characterization Kit manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Human iPS Cell Characterization Kit manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Human iPS Cell Characterization Kit sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Human iPS Cell Characterization Kit Market Overview
1.1 Product Definition
1.2 Human iPS Cell Characterization Kit by Type
1.2.1 Global Human iPS Cell Characterization Kit Market Value by Type: 2025 vs 2032
1.2.2 Alkaline Phosphatase Staining Assay
1.2.3 Pluripotency Markers (Protein)
1.2.4 Pluripotency Markers (mRNA)
1.3 Human iPS Cell Characterization Kit by Application
1.3.1 Global Human iPS Cell Characterization Kit Market Value by Application: 2025 vs 2032
1.3.2 Cancer Research Center
1.3.3 Pathology Laboratory
1.3.4 Academic and Research
1.3.5 Contract Research Organizations
1.3.6 Others
1.4 Global Human iPS Cell Characterization Kit Market Size Estimates and Forecasts
1.4.1 Global Human iPS Cell Characterization Kit Revenue 2021–2032
1.4.2 Global Human iPS Cell Characterization Kit Sales 2021–2032
1.4.3 Global Human iPS Cell Characterization Kit Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Human iPS Cell Characterization Kit Market Competition by Manufacturers
2.1 Global Human iPS Cell Characterization Kit Sales Market Share by Manufacturers (2021–2026)
2.2 Global Human iPS Cell Characterization Kit Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Human iPS Cell Characterization Kit Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Human iPS Cell Characterization Kit, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Human iPS Cell Characterization Kit, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Human iPS Cell Characterization Kit, Product Types and Applications
2.7 Global Key Manufacturers of Human iPS Cell Characterization Kit, Date of Entry into the Industry
2.8 Global Human iPS Cell Characterization Kit Market Competitive Situation and Trends
2.8.1 Global Human iPS Cell Characterization Kit Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Human iPS Cell Characterization Kit Players Market Share by Revenue
2.8.3 Global Human iPS Cell Characterization Kit Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human iPS Cell Characterization Kit Market Scenario by Region
3.1 Global Human iPS Cell Characterization Kit Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Human iPS Cell Characterization Kit Sales by Region: 2021–2032
3.2.1 Global Human iPS Cell Characterization Kit Sales by Region: 2021–2026
3.2.2 Global Human iPS Cell Characterization Kit Sales by Region: 2027–2032
3.3 Global Human iPS Cell Characterization Kit Revenue by Region: 2021–2032
3.3.1 Global Human iPS Cell Characterization Kit Revenue by Region: 2021–2026
3.3.2 Global Human iPS Cell Characterization Kit Revenue by Region: 2027–2032
3.4 North America Human iPS Cell Characterization Kit Market Facts & Figures by Country
3.4.1 North America Human iPS Cell Characterization Kit Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Human iPS Cell Characterization Kit Sales by Country (2021–2032)
3.4.3 North America Human iPS Cell Characterization Kit Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human iPS Cell Characterization Kit Market Facts & Figures by Country
3.5.1 Europe Human iPS Cell Characterization Kit Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Human iPS Cell Characterization Kit Sales by Country (2021–2032)
3.5.3 Europe Human iPS Cell Characterization Kit Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human iPS Cell Characterization Kit Market Facts & Figures by Region
3.6.1 Asia Pacific Human iPS Cell Characterization Kit Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Human iPS Cell Characterization Kit Sales by Region (2021–2032)
3.6.3 Asia Pacific Human iPS Cell Characterization Kit Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Human iPS Cell Characterization Kit Market Facts & Figures by Country
3.7.1 Latin America Human iPS Cell Characterization Kit Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Human iPS Cell Characterization Kit Sales by Country (2021–2032)
3.7.3 Latin America Human iPS Cell Characterization Kit Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human iPS Cell Characterization Kit Market Facts & Figures by Country
3.8.1 Middle East and Africa Human iPS Cell Characterization Kit Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Human iPS Cell Characterization Kit Sales by Country (2021–2032)
3.8.3 Middle East and Africa Human iPS Cell Characterization Kit Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human iPS Cell Characterization Kit Sales by Type (2021–2032)
4.1.1 Global Human iPS Cell Characterization Kit Sales by Type (2021–2026)
4.1.2 Global Human iPS Cell Characterization Kit Sales by Type (2027–2032)
4.1.3 Global Human iPS Cell Characterization Kit Sales Market Share by Type (2021–2032)
4.2 Global Human iPS Cell Characterization Kit Revenue by Type (2021–2032)
4.2.1 Global Human iPS Cell Characterization Kit Revenue by Type (2021–2026)
4.2.2 Global Human iPS Cell Characterization Kit Revenue by Type (2027–2032)
4.2.3 Global Human iPS Cell Characterization Kit Revenue Market Share by Type (2021–2032)
4.3 Global Human iPS Cell Characterization Kit Price by Type (2021–2032)
5 Segment by Application
5.1 Global Human iPS Cell Characterization Kit Sales by Application (2021–2032)
5.1.1 Global Human iPS Cell Characterization Kit Sales by Application (2021–2026)
5.1.2 Global Human iPS Cell Characterization Kit Sales by Application (2027–2032)
5.1.3 Global Human iPS Cell Characterization Kit Sales Market Share by Application (2021–2032)
5.2 Global Human iPS Cell Characterization Kit Revenue by Application (2021–2032)
5.2.1 Global Human iPS Cell Characterization Kit Revenue by Application (2021–2026)
5.2.2 Global Human iPS Cell Characterization Kit Revenue by Application (2027–2032)
5.2.3 Global Human iPS Cell Characterization Kit Revenue Market Share by Application (2021–2032)
5.3 Global Human iPS Cell Characterization Kit Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Merck KGaA
6.1.1 Merck KGaA Company Information
6.1.2 Merck KGaA Description and Business Overview
6.1.3 Merck KGaA Human iPS Cell Characterization Kit Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Merck KGaA Human iPS Cell Characterization Kit Product Portfolio
6.1.5 Merck KGaA Recent Developments/Updates
6.2 Takara Bio
6.2.1 Takara Bio Company Information
6.2.2 Takara Bio Description and Business Overview
6.2.3 Takara Bio Human iPS Cell Characterization Kit Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Takara Bio Human iPS Cell Characterization Kit Product Portfolio
6.2.5 Takara Bio Recent Developments/Updates
6.3 Thermo Fisher Scientific
6.3.1 Thermo Fisher Scientific Company Information
6.3.2 Thermo Fisher Scientific Description and Business Overview
6.3.3 Thermo Fisher Scientific Human iPS Cell Characterization Kit Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Thermo Fisher Scientific Human iPS Cell Characterization Kit Product Portfolio
6.3.5 Thermo Fisher Scientific Recent Developments/Updates
6.4 BD Biosciences
6.4.1 BD Biosciences Company Information
6.4.2 BD Biosciences Description and Business Overview
6.4.3 BD Biosciences Human iPS Cell Characterization Kit Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 BD Biosciences Human iPS Cell Characterization Kit Product Portfolio
6.4.5 BD Biosciences Recent Developments/Updates
6.5 Applied StemCell
6.5.1 Applied StemCell Company Information
6.5.2 Applied StemCell Description and Business Overview
6.5.3 Applied StemCell Human iPS Cell Characterization Kit Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Applied StemCell Human iPS Cell Characterization Kit Product Portfolio
6.5.5 Applied StemCell Recent Developments/Updates
6.6 Amsbio
6.6.1 Amsbio Company Information
6.6.2 Amsbio Description and Business Overview
6.6.3 Amsbio Human iPS Cell Characterization Kit Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Amsbio Human iPS Cell Characterization Kit Product Portfolio
6.6.5 Amsbio Recent Developments/Updates
6.7 Bio-Techne
6.7.1 Bio-Techne Company Information
6.7.2 Bio-Techne Description and Business Overview
6.7.3 Bio-Techne Human iPS Cell Characterization Kit Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Bio-Techne Human iPS Cell Characterization Kit Product Portfolio
6.7.5 Bio-Techne Recent Developments/Updates
6.8 ALSTEM
6.8.1 ALSTEM Company Information
6.8.2 ALSTEM Description and Business Overview
6.8.3 ALSTEM Human iPS Cell Characterization Kit Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 ALSTEM Human iPS Cell Characterization Kit Product Portfolio
6.8.5 ALSTEM Recent Developments/Updates
6.9 STEMCELL Technologies
6.9.1 STEMCELL Technologies Company Information
6.9.2 STEMCELL Technologies Description and Business Overview
6.9.3 STEMCELL Technologies Human iPS Cell Characterization Kit Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 STEMCELL Technologies Human iPS Cell Characterization Kit Product Portfolio
6.9.5 STEMCELL Technologies Recent Developments/Updates
6.10 System Biosciences
6.10.1 System Biosciences Company Information
6.10.2 System Biosciences Description and Business Overview
6.10.3 System Biosciences Human iPS Cell Characterization Kit Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 System Biosciences Human iPS Cell Characterization Kit Product Portfolio
6.10.5 System Biosciences Recent Developments/Updates
6.11 Applied Biological Materials
6.11.1 Applied Biological Materials Company Information
6.11.2 Applied Biological Materials Description and Business Overview
6.11.3 Applied Biological Materials Human iPS Cell Characterization Kit Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Applied Biological Materials Human iPS Cell Characterization Kit Product Portfolio
6.11.5 Applied Biological Materials Recent Developments/Updates
6.12 Creative Bioarray
6.12.1 Creative Bioarray Company Information
6.12.2 Creative Bioarray Description and Business Overview
6.12.3 Creative Bioarray Human iPS Cell Characterization Kit Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Creative Bioarray Human iPS Cell Characterization Kit Product Portfolio
6.12.5 Creative Bioarray Recent Developments/Updates
6.13 Elixirgen Scientific
6.13.1 Elixirgen Scientific Company Information
6.13.2 Elixirgen Scientific Description and Business Overview
6.13.3 Elixirgen Scientific Human iPS Cell Characterization Kit Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Elixirgen Scientific Human iPS Cell Characterization Kit Product Portfolio
6.13.5 Elixirgen Scientific Recent Developments/Updates
6.14 Miltenyi Biotec
6.14.1 Miltenyi Biotec Company Information
6.14.2 Miltenyi Biotec Description and Business Overview
6.14.3 Miltenyi Biotec Human iPS Cell Characterization Kit Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Miltenyi Biotec Human iPS Cell Characterization Kit Product Portfolio
6.14.5 Miltenyi Biotec Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human iPS Cell Characterization Kit Industry Chain Analysis
7.2 Human iPS Cell Characterization Kit Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human iPS Cell Characterization Kit Production Mode & Process Analysis
7.4 Human iPS Cell Characterization Kit Sales and Marketing
7.4.1 Human iPS Cell Characterization Kit Sales Channels
7.4.2 Human iPS Cell Characterization Kit Distributors
7.5 Human iPS Cell Characterization Kit Customer Analysis
8 Human iPS Cell Characterization Kit Market Dynamics
8.1 Human iPS Cell Characterization Kit Industry Trends
8.2 Human iPS Cell Characterization Kit Market Drivers
8.3 Human iPS Cell Characterization Kit Market Challenges
8.4 Human iPS Cell Characterization Kit Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Human iPS Cell Characterization Kit was estimated to be worth US$ 1148 million in 2025 and is projected to reach US$ 1927 million, growing at a CAGR of 7.8% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 138
USD 3950.00
(Single User License)
The global Human iPS Cell Characterization Kit market size was US$ 1072 million in 2024 and is forecast to a readjusted size of US$ 1801 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 94
USD 4250.00
(Single User License)
The global Human iPS Cell Characterization Kit market is projected to grow from US$ 1072 million in 2024 to US$ 1801 million by 2031, at a CAGR of 7.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 157
USD 4900.00
(Single User License)
The global market for Human iPS Cell Characterization Kit was estimated to be worth US$ 1072 million in 2024 and is forecast to a readjusted size of US$ 1801 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 119
USD 3950.00
(Single User License)
The global market for Human iPS Cell Characterization Kit was valued at US$ 1072 million in the year 2024 and is projected to reach a revised size of US$ 1801 million by 2031, growing at a CAGR of 7.8% during the forecast period.
Published Date: 2025-01-13
Pages: 93
USD 2900.00
(Single User License)
The Human iPS Cell Characterization Kit (Induced pluripotent stem cell) contains a range of sensitive tools for the phenotypic assessment of the pluripotent status of human Embryonic stem & induced pluripotent Stem cells.
Published Date: 2024-04-10
Pages: 112
USD 4900.00
(Single User License)
The Human iPS Cell Characterization Kit (Induced pluripotent stem cell) contains a range of sensitive tools for the phenotypic assessment of the pluripotent status of human Embryonic stem & induced pluripotent Stem cells.
Published Date: 2024-01-17
Pages: 94
USD 2900.00
(Single User License)
The global market for Human iPS Cell Characterization Kit was estimated to be worth US$ 1148 million in 2025 and is projected to reach US$ 1927 million, growing at a CAGR of 7.8% from 2026 to 2032.
Published: 2026-06-16
Pages: 138
The global Human iPS Cell Characterization Kit market size was US$ 1072 million in 2024 and is forecast to a readjusted size of US$ 1801 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 94
The global Human iPS Cell Characterization Kit market is projected to grow from US$ 1072 million in 2024 to US$ 1801 million by 2031, at a CAGR of 7.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 157
The global market for Human iPS Cell Characterization Kit was estimated to be worth US$ 1072 million in 2024 and is forecast to a readjusted size of US$ 1801 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 119
The global market for Human iPS Cell Characterization Kit was valued at US$ 1072 million in the year 2024 and is projected to reach a revised size of US$ 1801 million by 2031, growing at a CAGR of 7.8% during the forecast period.
Published: 2025-01-13
Pages: 93
The Human iPS Cell Characterization Kit (Induced pluripotent stem cell) contains a range of sensitive tools for the phenotypic assessment of the pluripotent status of human Embryonic stem & induced pluripotent Stem cells.
Published: 2024-04-10
Pages: 112
The Human iPS Cell Characterization Kit (Induced pluripotent stem cell) contains a range of sensitive tools for the phenotypic assessment of the pluripotent status of human Embryonic stem & induced pluripotent Stem cells.
Published: 2024-01-17
Pages: 94
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now